Showing results (411-420 of 630) with videos related to

Sort By:
Pageof 63
Journal of Autoimmunity|September 7, 2019
Efficacy and safety of mycophenolate mofetil in patients with virus-negative lymphocytic myocarditis: A prospective cohort studyGiacomo De Luca, Corrado Campochiaro, Silvia Sartorelli, et al.
Heart Rhythm|November 27, 2018
Arrhythmias in myocarditis: State of the artGiovanni Peretto, Simone Sala, Stefania Rizzo, et al.
Rheumatology (Oxford, England)|April 5, 2023
Validation of the 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritisAlessandro Tomelleri, Roberto Padoan, Chengappa G Kavadichanda, et al.
Investigative Ophthalmology & Visual Science|January 15, 1999
Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expressionH Ozaki, A Y Yu, N Della, et al.
Human Gene Therapy|March 5, 2003
Periocular gene transfer of sFlt-1 suppresses ocular neovascularization and vascular endothelial growth factor-induced breakdown of the blood-retinal barrierPeter Gehlbach, Anna Maria Demetriades, Satoru Yamamoto, et al.
Journal of the American College of Cardiology|March 7, 2020
Ventricular Arrhythmias in Myocarditis: Characterization and Relationships With Myocardial InflammationGiovanni Peretto, Simone Sala, Stefania Rizzo, et al.
American Journal of Ophthalmology|December 7, 2007
Intravenous bevacizumab causes regression of choroidal neovascularization secondary to diseases other than age-related macular degenerationQuan Dong Nguyen, Syed Mahmood Shah, Gulnar Hafiz, et al.
Ophthalmology|October 7, 2016
Twenty-four-Month Outcomes of the Ranibizumab for Edema of the Macula in Diabetes - Protocol 3 with High Dose (READ-3) StudyYasir J Sepah, Mohammad Ali Sadiq, David Boyer, et al.
Ophthalmology|July 16, 2010
Antagonism of vascular endothelial growth factor for macular edema caused by retinal vein occlusions: two-year outcomesPeter A Campochiaro, Gulnar Hafiz, Roomasa Channa, et al.
Oncoimmunology|September 14, 2016
Plasma Chromogranin A as a marker of cardiovascular involvement in Erdheim-Chester diseaseElisabetta Ferrero, Angelo Corti, Julien Haroche, et al.
Pageof 63